Insider Transactions in Q4 2025 at Theravance Biopharma, Inc. (TBPH)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 26
2025
|
Eran Broshy |
SELL
Open market or private sale
|
Direct |
29,501
-22.31%
|
$590,020
$20.0 P/Share
|
|
Nov 20
2025
|
Aine Miller SVP, DEV & HEAD OF IRE OFFICE |
SELL
Payment of exercise price or tax liability
|
Direct |
6,989
-3.36%
|
$118,813
$17.9 P/Share
|
|
Nov 20
2025
|
Aziz Sawaf SVP & CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
18,627
-5.24%
|
$316,659
$17.9 P/Share
|
|
Nov 20
2025
|
Rhonda Farnum SVP, COMM & MEDICAL AFFAIRS |
SELL
Payment of exercise price or tax liability
|
Direct |
9,060
-2.85%
|
$154,020
$17.9 P/Share
|
|
Nov 20
2025
|
Brett A. Grimaud SVP, GEN COUNSEL AND SECRETARY |
SELL
Payment of exercise price or tax liability
|
Direct |
19,024
-5.08%
|
$323,408
$17.9 P/Share
|
|
Nov 20
2025
|
Rick E Winningham CHIEF EXECUTIVE OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
56,817
-3.33%
|
$965,889
$17.9 P/Share
|
|
Nov 19
2025
|
Rick E Winningham CHIEF EXECUTIVE OFFICER |
BUY
Bona fide gift
|
Indirect |
9,900
+29.73%
|
-
|
|
Nov 19
2025
|
Rick E Winningham CHIEF EXECUTIVE OFFICER |
SELL
Bona fide gift
|
Direct |
9,900
-0.58%
|
-
|
|
Nov 11
2025
|
Eran Broshy |
SELL
Open market or private sale
|
Direct |
59,000
-26.91%
|
$1,062,000
$18.0 P/Share
|